Lund Vasculitis Epidemiology Research Group
31 – 40 of 62
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2022
-
Mark
Complement activation prior to symptom onset in myeloperoxidase ANCA-associated vasculitis but not proteinase 3 ANCA associated vasculitis - A Swedish biobank study
- Contribution to journal › Article
-
Mark
Clustering of anti-neutrophil cytoplasmic antibody-associated vasculitis - using a pre-processed harmonised dataset
(2022) 20th International Vasculitis and ANCA workshop
- Contribution to conference › Abstract
-
Mark
An update on the epidemiology of Behçet’s disease in southern Sweden
(2022) 20th International Vasculitis and ANCA workshop
- Contribution to conference › Abstract
-
Mark
Myocardial infarction in ANCA-associated vasculitis- a population-based cohort-study
(2022) 20th International Vasculitis and ANCA workshop
- Contribution to conference › Abstract
-
Mark
Epidemiology and Clinical Characteristics of Adult-Onset IgA Vasculitis in Southern Sweden
(2022) 20th International Vasculitis and ANCA workshop
- Contribution to conference › Abstract
-
Mark
No evidence that sun exposure can decrease the risk of vasculitis
(2022) 20th International Vasculitis and ANCA workshop
- Contribution to conference › Abstract
-
Mark
Infection is associated with increased risk of MPO- but not PR3-ANCA associated vasculitis
- Contribution to journal › Article
-
Mark
Mepolizumab for Eosinophilic Granulomatosis With Polyangiitis: A European Multicenter Observational Study
- Contribution to journal › Article
- 2021
-
Mark
Epidemiology of biopsy-confirmed giant cell arteritis in southern Sweden - an update on incidence and first prevalence estimate
- Contribution to journal › Article
-
Mark
Trajectory of Healthcare Resources Utilization in Giant Cell Arteritis – A Population-Based Study
- Contribution to journal › Article
